Liposome delivery systems for the treatment of Alzheimer’s disease

Código QR

Liposome delivery systems for the treatment of Alzheimer’s disease

Callum Ross, Mark Taylor, Nigel Fullwood, David Allsop Division of Biomedical and Life Sciences, Faculty of Health and Medicine, Lancaster University, Lancaster LA1 4YQ, UK Abstract: Alzheimer’s disease (AD) will affect around 115 million people worldwide by the year 2050. It is...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ross C, Taylor M, Fullwood N, Allsop D
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2018
Materias:	amyloid blood brain barrier cell penetrating peptides neurofibrillary tangles senile plaques Tau Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/9126dfe615c4476aba3128261a4a69de
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Association between Sleep, Alzheimer’s, and Parkinson’s Disease
por: Sumire Matsumoto, et al.
Publicado: (2021)

Microglia astrocyte interaction in Alzheimer's disease: friends or foes for the nervous system?
por: VON BERNHARDI,ROMMY, et al.
Publicado: (2001)

Detection of hyperphosphorylated tau protein and α-synuclein in spinal cord of patients with Alzheimer’s disease
por: Guo YJ, et al.
Publicado: (2016)

Liposome based drug delivery as a potential treatment option for Alzheimer’s disease
por: Carely Hernandez, et al.
Publicado: (2022)

Wheat germ agglutinin-conjugated liposomes incorporated with cardiolipin to improve neuronal survival in Alzheimer’s disease treatment
por: Kuo YC, et al.
Publicado: (2017)

Salivary Biomarkers in Alzheimer´s Disease
por: Santos,Gustavo A. A, et al.
Publicado: (2020)

Extensive frontal focused ultrasound mediated blood–brain barrier opening for the treatment of Alzheimer’s disease: a proof-of-concept study
por: So Hee Park, et al.
Publicado: (2021)

Hyperphosphorylation of Tau Due to the Interference of Protein Phosphatase Methylesterase-1 Overexpression by MiR-125b-5p in Melatonin Receptor Knockout Mice
por: Han Zhao, et al.
Publicado: (2021)

Cien años de la enfermedad de Alzheimer: La inmunoterapia ¿una esperanza?
por: Behrens P,María Isabel, et al.
Publicado: (2007)

Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics
por: Tiwari S, et al.
Publicado: (2019)

Periodontal Disease and Periodontal Disease-Related Bacteria Involved in the Pathogenesis of Alzheimer’s Disease
por: Matsushita K, et al.
Publicado: (2020)

Transferrin-Modified Osthole PEGylated Liposomes Travel the Blood-Brain Barrier and Mitigate Alzheimer’s Disease-Related Pathology in APP/PS-1 Mice
por: Kong L, et al.
Publicado: (2020)

Role of Lipocalin-2 in Amyloid-Beta Oligomer-Induced Mouse Model of Alzheimer’s Disease
por: Heeyoung Kang, et al.
Publicado: (2021)

CCR5 antagonist reduces HIV-induced amyloidogenesis, tau pathology, neurodegeneration, and blood-brain barrier alterations in HIV-infected hu-PBL-NSG mice
por: Biju Bhargavan, et al.
Publicado: (2021)

Overcoming the Blood–Brain Barrier: Successes and Challenges in Developing Nanoparticle-Mediated Drug Delivery Systems for the Treatment of Brain Tumours
por: Ferraris C, et al.
Publicado: (2020)

Peptide-Based Vaccines for Neurodegenerative Diseases: Recent Endeavors and Future Perspectives
por: Vyronia Vassilakopoulou, et al.
Publicado: (2021)

Positron Emission Tomography in Animal Models of Alzheimer’s Disease Amyloidosis: Translational Implications
por: Ruiqing Ni
Publicado: (2021)

Multifunctional Nanopolymers for Blood–Brain Barrier Delivery and Inhibition of Glioblastoma Growth through EGFR/EGFRvIII, c-Myc, and PD-1
por: Rameshwar Patil, et al.
Publicado: (2021)

Role of berberine in Alzheimer’s disease
por: Cai Z, et al.
Publicado: (2016)

The effect of dexamethasone/cell-penetrating peptide nanoparticles on gene delivery for inner ear therapy
por: Yoon JY, et al.
Publicado: (2016)

Improving Cell Penetration of Gold Nanorods by Using an Amphipathic Arginine Rich Peptide
por: Riveros AL, et al.
Publicado: (2020)

PPARγ agonist-loaded PLGA-PEG nanocarriers as a potential treatment for Alzheimer’s disease: in vitro and in vivo studies
por: Silva-Abreu M, et al.
Publicado: (2018)

Synthesis and characterization of a novel peptide-grafted Cs and evaluation of its nanoparticles for the oral delivery of insulin, in vitro, and in vivo study
por: Barbari GR, et al.
Publicado: (2018)

Microglia in Alzheimer’s Disease: A Target for Therapeutic Intervention
por: Guimei Zhang, et al.
Publicado: (2021)

Investigation of the Transport Pathways Associated with Enhanced Brain Delivery of Peptide Drugs by Intranasal Coadministration with Penetratin
por: Noriyasu Kamei, et al.
Publicado: (2021)

Rhynchophylline Loaded-mPEG-PLGA Nanoparticles Coated with Tween-80 for Preliminary Study in Alzheimer’s Disease
por: Xu R, et al.
Publicado: (2020)

In vivo Glioblastoma Therapy Using Targeted Liposomal Cisplatin
por: Ashrafzadeh MS, et al.
Publicado: (2020)

Modulation of the intrinsic neuronal excitability by multifunctional liposomes tailored for the treatment of Alzheimer's disease
por: Binda A, et al.
Publicado: (2018)

Association of a Total Cholesterol Polygenic Score with Cholesterol Levels and Pathological Biomarkers across the Alzheimer’s Disease Spectrum
por: Nathalie I. V. Nilsson, et al.
Publicado: (2021)

Getting into the brain: liposome-based strategies for effective drug delivery across the blood–brain barrier
por: Vieira DB, et al.
Publicado: (2016)

Type 2 diabetes as a risk factor for cognitive impairment: current insights
por: Umegaki H
Publicado: (2014)

Polymeric Nanoparticles-Based Brain Delivery with Improved Therapeutic Efficacy of Ginkgolide B in Parkinson’s Disease
por: Zhao Y, et al.
Publicado: (2020)

The functional curcumin liposomes induce apoptosis in C6 glioblastoma cells and C6 glioblastoma stem cells in vitro and in animals
por: Wang YH, et al.
Publicado: (2017)

Matrix metalloproteinase-9 and p53 involved in chronic fluorosis induced blood-brain barrier damage and neurocyte changes
por: Shen Qing-Feng, et al.
Publicado: (2019)

Inhibition of tumor metastasis by targeted daunorubicin and dioscin codelivery liposomes modified with PFV for the treatment of non-small-cell lung cancer
por: Wang Y, et al.
Publicado: (2019)

Peptide-Based Drug Delivery Systems
por: Dmitriy Berillo, et al.
Publicado: (2021)

Pathoanatomical Pattern of Brain Damage of White Mice Infected with Experimental Anthrax
por: D. D. Briukhova, et al.
Publicado: (2020)

Tight Junctions of the Neurovascular Unit
por: Natalie Hudson, et al.
Publicado: (2021)

INTERNALIZATION OF ANTIMICROBIAL PEPTIDE ACIPENSIN 1 INTO HUMAN TUMOR CELLS
por: E. S. Umnyakova, et al.
Publicado: (2016)

Tat-functionalized liposomes for the treatment of meningitis: an in vitro study
por: Bartomeu Garcia C, et al.
Publicado: (2017)